Your company account is blocked and you cannot place orders. If you have questions, please contact your company administrator.

Phosphoric acid mono-(4-{(S)-2-acetylamino-2-[(S)-1-(1-{(S)-3-carbamoyl-1-[(1S,2R)-1-((S)-1-carbamoyl-2-methyl-propylcarbamoyl)-2-hydroxy-propylcarbamoyl]-propylcarbamoyl}-ethylcarbamoyl)-3-methyl-butylcarbamoyl]-ethyl}-phenyl) ester

ID: ALA156046

PubChem CID: 44372037

Max Phase: Preclinical

Molecular Formula: C34H55N8O13P

Molecular Weight: 814.83

Molecule Type: Small molecule

This compound is available for customization.

Associated Items:

Names and Identifiers

Canonical SMILES:  CC(=O)N[C@@H](Cc1ccc(OP(=O)(O)O)cc1)C(=O)N[C@@H](CC(C)C)C(=O)NC(C)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@H](C(=O)N[C@H](C(N)=O)C(C)C)[C@@H](C)O

Standard InChI:  InChI=1S/C34H55N8O13P/c1-16(2)14-24(40-33(50)25(38-20(7)44)15-21-8-10-22(11-9-21)55-56(52,53)54)32(49)37-18(5)30(47)39-23(12-13-26(35)45)31(48)42-28(19(6)43)34(51)41-27(17(3)4)29(36)46/h8-11,16-19,23-25,27-28,43H,12-15H2,1-7H3,(H2,35,45)(H2,36,46)(H,37,49)(H,38,44)(H,39,47)(H,40,50)(H,41,51)(H,42,48)(H2,52,53,54)/t18?,19-,23+,24+,25+,27+,28+/m1/s1

Standard InChI Key:  KYVXVUVUYXERCR-FLVQWASHSA-N

Molfile:  

     RDKit          2D

 56 56  0  0  1  0  0  0  0  0999 V2000
   10.3417  -16.5500    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    9.5917  -16.8792    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    8.9167  -16.3917    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   11.0167  -17.0375    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   -2.2083  -19.8375    0.0000 P   0  0  0  0  0  0  0  0  0  0  0  0
    8.1667  -16.7292    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.9667  -18.2417    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.8917  -16.2667    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    6.0792  -16.0792    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.0417  -17.4250    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    6.7417  -16.5750    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    4.6542  -15.9292    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   11.7667  -16.7000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.8042  -17.0875    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.2042  -18.5792    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   12.4417  -17.1917    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.1167  -19.4000    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    7.4917  -16.2417    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    5.3167  -16.4167    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.7792  -19.8875    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.4958  -19.4292    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    8.4292  -14.2625    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.6208  -19.1167    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   10.4417  -15.7292    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    8.0792  -17.5500    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    3.2292  -15.7750    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    3.5500  -18.2917    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    6.1667  -15.2625    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    1.5417  -18.0917    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   12.3542  -18.0125    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    4.4667  -17.5750    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    9.5042  -17.7042    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.5292  -19.5542    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    9.1917  -13.9292    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    7.5917  -15.4167    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.9208  -20.2417    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   -1.8083  -20.5542    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   13.1917  -16.8542    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   11.8667  -15.8792    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    8.3417  -15.0792    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.7333  -19.0917    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    7.7667  -13.7667    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.7792  -18.4250    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.6917  -19.2417    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.1167  -17.9375    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.0708  -19.5792    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.6458  -18.2667    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   10.1667  -18.1917    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    4.3792  -18.3917    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.6917  -20.7042    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    5.2292  -17.2417    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    8.7417  -18.0417    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   12.6167  -15.5417    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   11.1917  -15.3917    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.9667  -19.1042    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    5.0542  -18.8792    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
  2  1  1  0
  2  3  1  6
  4  1  1  0
  5 21  1  0
  6  3  1  0
  7 10  1  0
  8 12  1  0
  9 11  1  0
 14 10  1  6
 18 11  1  1
 12 19  1  0
 13  4  1  1
 14  8  1  0
 15  7  1  0
 16 13  1  0
 15 17  1  1
 18  6  1  0
 19  9  1  0
 20 17  1  0
 21 41  1  0
 22 40  1  0
 23  5  2  0
 24  1  2  0
 25  6  2  0
 26  8  2  0
 27  7  2  0
 28  9  2  0
 15 29  1  0
 30 16  2  0
 14 31  1  0
  2 32  1  0
 33 20  2  0
 34 22  2  0
 18 35  1  0
 36  5  1  0
 37  5  1  0
 38 16  1  0
 13 39  1  0
 40 35  1  0
 41 47  2  0
 42 22  1  0
 43 29  1  0
 44 43  1  0
 45 43  2  0
 46 44  2  0
 47 45  1  0
 32 48  1  6
 49 31  1  0
 50 20  1  0
 51 19  1  0
 52 32  1  0
 53 39  1  0
 54 39  1  0
 55 49  1  0
 56 49  1  0
 41 46  1  0
M  END

Alternative Forms

Associated Targets(Human)

STAT3 Tchem Signal transducer and activator of transcription 3 (3313 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Calculated Properties

Molecular Weight: 814.83Molecular Weight (Monoisotopic): 814.3626AlogP: -2.52#Rotatable Bonds: 23
Polar Surface Area: 347.77Molecular Species: ACIDHBA: 11HBD: 11
#RO5 Violations: 3HBA (Lipinski): 21HBD (Lipinski): 13#RO5 Violations (Lipinski): 3
CX Acidic pKa: 1.79CX Basic pKa: CX LogP: -3.20CX LogD: -6.31
Aromatic Rings: 1Heavy Atoms: 56QED Weighted: 0.05Np Likeness Score: 0.18

References

1. Ren Z, Cabell LA, Schaefer TS, McMurray JS..  (2003)  Identification of a high-affinity phosphopeptide inhibitor of Stat3.,  13  (4): [PMID:12639546] [10.1016/s0960-894x(02)01050-8]
2. Mandal, Pijus K PK and 9 more authors.  2009-04-23  Conformationally constrained peptidomimetic inhibitors of signal transducer and activator of transcription. 3: Evaluation and molecular modeling.  [PMID:19334714]
3. Mandal, Pijus K; Ren, Zhiyong; Chen, Xiaomin; Xiong, Chiyi and McMurray, John S.  2009-10-08  Structure-affinity relationships of glutamine mimics incorporated into phosphopeptides targeted to the SH2 domain of signal transducer and activator of transcription 3.  [PMID:19728728]
4. Ioannidis, Stephanos S and 20 more authors.  2011-01-13  Discovery of 5-chloro-N2-[(1S)-1-(5-fluoropyrimidin-2-yl)ethyl]-N4-(5-methyl-1H-pyrazol-3-yl)pyrimidine-2,4-diamine (AZD1480) as a novel inhibitor of the Jak/Stat pathway.  [PMID:21138246]
5. Mandal, Pijus K and 10 more authors.  2011-05-26  Potent and selective phosphopeptide mimetic prodrugs targeted to the Src homology 2 (SH2) domain of signal transducer and activator of transcription 3.  [PMID:21486047]
6. Ren, Xiaomei X and 8 more authors.  2010-12-09  Identification of Niclosamide as a New Small-Molecule Inhibitor of the STAT3 Signaling Pathway.  [PMID:24900231]
7. Haftchenary, Sina S and 15 more authors.  2013-11-14  Potent Targeting of the STAT3 Protein in Brain Cancer Stem Cells: A Promising Route for Treating Glioblastoma.  [PMID:24900612]
8. LaPorte, Matthew G and 11 more authors.  2014-11-01  2-Guanidinoquinazolines as new inhibitors of the STAT3 pathway.  [PMID:25288188]
9. Miklossy, Gabriella G and 15 more authors.  2015-10-08  Hirsutinolide Series Inhibit Stat3 Activity, Alter GCN1, MAP1B, Hsp105, G6PD, Vimentin, TrxR1, and Importin α-2 Expression, and Induce Antitumor Effects against Human Glioma.  [PMID:26331426]
10. Löcken, Hauke H, Clamor, Cinzia C and Müller, Klaus K.  2018-07-27  Napabucasin and Related Heterocycle-Fused Naphthoquinones as STAT3 Inhibitors with Antiproliferative Activity against Cancer Cells.  [PMID:30003778]
11. Huang, Wei W and 8 more authors.  2018-09-05  Small-molecule compounds targeting the STAT3 DNA-binding domain suppress survival of cisplatin-resistant human ovarian cancer cells by inducing apoptosis.  [PMID:30145375]
12. Chen, Shao-Ru SR and 7 more authors.  2018-10-01  Andrographolide derivative as STAT3 inhibitor that protects acute liver damage in mice.  [PMID:30228000]
13. Li, Chungen C and 8 more authors.  2019-01-15  A novel series of napabucasin derivatives as orally active inhibitors of signal transducer and activator of transcription 3 (STAT3).  [PMID:30472602]
14. Zhou, Haibin and 18 more authors.  2019-12-26  Structure-Based Discovery of SD-36 as a Potent, Selective, and Efficacious PROTAC Degrader of STAT3 Protein.  [PMID:31747516]
15. Kaoud, Tamer S and 7 more authors.  2020-01-15  NO-releasing STAT3 inhibitors suppress BRAF-mutant melanoma growth.  [PMID:31784187]
16. Cerulli, Robert A and 6 more authors.  2020-06-15  Cytosolic delivery of peptidic STAT3 SH2 domain inhibitors.  [PMID:32503696]
17. Brotherton-Pleiss, Christine and 13 more authors.  2021-01-14  Discovery of Novel Azetidine Amides as Potent Small-Molecule STAT3 Inhibitors.  [PMID:33352047]

Source